Chameleon Biosciences is developing next-generation adeno-associated virus vectors that elicit minimal immune responses, allowing repeat dosing and resulting in superior efficacies. These EVADER ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback